Instrument Fundamentals
| Date | Close | Change | Change (%) | Open | High | Low |
|---|
News
Bristol-Myers Squibb (BMY) Receives a Hold from Wells Fargo | Markets Insider
Wells Fargo & Company Forecasts Strong Price Appreciation for Bristol Myers Squibb (NYSE:BMY) Stock - Markets Daily
Jefferies Remains Bullish on Bristol-Myers Squibb Company (BMY)
Did New Gotistobart Data Just Shift BioNTech's (BNTX) Oncology-Led Diversification Narrative? - Simply Wall St News
Daiwa Securities Group Inc. Raises Stock Holdings in Bristol Myers Squibb Company $BMY
Bank of Nova Scotia Buys 183,478 Shares of Bristol Myers Squibb Company $BMY
China's Fosun Pharma unit strikes US$2.1 billion obesity drug deal with Pfizer | South China Morning Post
Taking Stock of Bristol-Myers Squibb (BMY): Exploring Valuation After Recent Share Price Momentum
Somatic evolution following cancer treatment in normal tissue
Non-Hodgkin Lymphoma Clinical Trial Pipeline Accelerates as 180+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight
Global Market for Merkel Cell Carcinoma Driven by Key Players Like Merck & Bristol Myers Squibb
Myelofibrosis Market to Expand Significantly by 2034, States DelveInsight Report | Lynk Pharma, Samus Therapeutics, Taiga Biotech, Bristol-Myers Squibb, Sumitomo Pharma Oncology, Keros Therapeutics
Bristol Myers Squibb Company $BMY Shares Bought by Investment Management Corp of Ontario
State Street Corp Reduces Holdings in Bristol Myers Squibb Company $BMY
66,361 Shares in Bristol Myers Squibb Company $BMY Bought by SVB Wealth LLC
Natixis Sells 51,702 Shares of Bristol Myers Squibb Company $BMY
Bristol Myers Squibb (BMY) Is Up 5.1% After Expanded Breyanzi MZL Approval Has The Bull Case Changed?
Leerink Maintains Outperform Rating as Bristol Myers (BMY) Expands ADEPT-2 Enrollment
14,601 Shares in Bristol Myers Squibb Company $BMY Purchased by ESG Planning DBA Harper Investing - Daily Political
Mirabella Financial Services LLP Trims Stock Position in Bristol Myers Squibb Company $BMY
Bristol-Myers Squibb (BMY) Gets a Buy from Jefferies | Markets Insider
Amundi Purchases 513,255 Shares of Bristol Myers Squibb Company $BMY
91,645 Shares in Bristol Myers Squibb Company $BMY Acquired by 1832 Asset Management L.P.
Jim Cramer on Bristol-Myers' Recent Stock Gain: "Unbelievable"
Bristol Myers Squibb Company $BMY Shares Sold by Mirabella Financial Services LLP - Daily Political
Dodge & Cox Trims Position in Bristol Myers Squibb Company $BMY - Markets Daily
First Trust Advisors LP Has $212.59 Million Holdings in Bristol Myers Squibb Company $BMY
US Acute Myeloid Leukemia Market Size & Share Forecast 2025-2033 | Taiwan News | Dec. 5, 2025 10:13
Efficacy of eltrombopag for treatment of thrombocytopenia in the setting of allogeneic hematopoietic cell transplantation: a systematic review and meta-analysis
Results of delayed or salvage autologous hematopoietic stem cell transplantation for multiple myeloma
Tigerlily Foundation Launches the "Bliss Collective: Brunch & Sip" Series to Empower, Educate, and Uplift Women Nationwide | Morningstar
Jim Cramer Commented on 10 Stocks and the Recent Macro Rally
Phreesia News | Markets Insider
CW Advisors LLC Boosts Position in Bristol Myers Squibb Company $BMY - Markets Daily
CW Advisors LLC Increases Stock Holdings in Bristol Myers Squibb Company $BMY
A delayed clinical trial actually boosted Bristol Myers Squibb's stock. Here's why. | Morningstar
insitro Appoints R&D Veteran Stephen Hitchcock and AI Visionary Vijay Pande as Scientific Advisors
Independent Franchise Partners LLP Increases Holdings in Bristol Myers Squibb Company $BMY
The Bull Case For BioNTech (BNTX) Could Change Following Higher Guidance And Oncology Progress - Learn Why
Bristol-Myers Squibb (BMY): Assessing Value After a Recent Short-Term Share Price Rebound
River Road Asset Management LLC Decreases Position in Bristol Myers Squibb Company $BMY - Markets Daily
Me Too Drugs Industry Research Report 2025: Market to Reach $541.86 Million by 2030, Driven by Lower R&D Risk, Therapeutic Alternatives, and Opportunities from Patent Expirations
Smith Moore & CO. Decreases Stake in Bristol Myers Squibb Company $BMY - Markets Daily
River Road Asset Management LLC Sells 67,650 Shares of Bristol Myers Squibb Company $BMY - Stock Observer
Research Analysts' Recent Ratings Updates for Bristol Myers Squibb (BMY) - Markets Daily
Edgestream Partners L.P. Acquires 85,066 Shares of Bristol Myers Squibb Company $BMY
Bristol Myers Squibb Company $BMY Shares Acquired by Arrowstreet Capital Limited Partnership
Smith Moore & CO. Sells 1,262 Shares of Bristol Myers Squibb Company $BMY - Stock Observer
Lymphoma risk in autoimmune diseases with multiple medication use: analysis from the LIFE Study
Biologics Manufacturing Market: Segment Forecasts Across Global Regions - Express Press Release Distribution
Wealthedge Investment Advisors LLC Buys New Holdings in Bristol Myers Squibb Company $BMY - Markets Daily
Bristol Myers Squibb Company $BMY Shares Purchased by Railway Pension Investments Ltd
Round Hill Asset Management Buys 30,016 Shares of Bristol Myers Squibb Company $BMY - Stock Observer
Shelton Capital Management Cuts Stock Holdings in Bristol Myers Squibb Company $BMY - Daily Political
Claret Asset Management Corp Increases Stock Position in Bristol Myers Squibb Company $BMY - Daily Political
BioNTech (BNTX) Is Up 7.9% After Raising 2025 Revenue Guidance on Bristol-Myers Collaboration
BMY Gains Attention as Bayer Reports FXIa Trial Success
Trustmark Bank Trust Department Sells 32,341 Shares of Bristol Myers Squibb Company $BMY - Markets Daily
West Family Investments Inc. Raises Stock Holdings in Bristol Myers Squibb Company $BMY - Markets Daily
Bristol Myers Squibb Company $BMY Holdings Trimmed by Financial Advocates Investment Management
Bristol Myers Squibb Company $BMY Position Cut by Boston Partners
Scotia Capital Inc. Grows Stake in Bristol Myers Squibb Company $BMY - Markets Daily
Bristol Myers Squibb Company $BMY Shares Purchased by Schroder Investment Management Group - Stock Observer
Bristol Myers Squibb Company (NYSE:BMY) Given Average Rating of "Hold" by Brokerages
Windtree Therapeutics (NASDAQ:WINT) and Bristol Myers Squibb (NYSE:BMY) Critical Comparison - Stock Observer
Bristol-Myers Squibb Surges 15% After Drug Approvals: Is the Stock a Bargain in 2025?
Measured Wealth Private Client Group LLC Has $661,000 Position in Bristol Myers Squibb Company $BMY - Stock Observer
Bristol Myers Squibb Company $BMY Shares Acquired by Skandinaviska Enskilda Banken AB publ - Stock Observer
Bristol-Myers Squibb Company (BMY): A Bull Case Theory - Insider Monkey
Follicular Lymphoma Market Trends, Opportunities, Growth Challenges and Competitive Intelligence 2025-2035
Bristol Myers Squibb Company $BMY Shares Purchased by Jefferies Financial Group Inc.
Employees Retirement System of Texas Has $12.90 Million Stock Holdings in Bristol Myers Squibb Company $BMY
Global Retirement Partners LLC Acquires Shares of 30,315 Bristol Myers Squibb Company $BMY - Daily Political
Towards biomarker-driven therapies for urothelial carcinoma
Consensus definitions of complex-to-manage and treatment-refractory psoriatic arthritis: a GRAPPA initiative
Bristol Myers Squibb Company $BMY Stake Cut by FourThought Financial Partners LLC - Markets Daily
Bristol Myers Squibb Company $BMY Shares Bought by Elo Mutual Pension Insurance Co
Bristol Myers Squibb Company $BMY Shares Sold by Advisors Asset Management Inc.
Jefferies Financial Group Inc. Boosts Stake in Bristol Myers Squibb Company $BMY - Daily Political
Clinical experience with cranial nerve palsy in patients infused with ciltacabtagene autoleucel for the treatment of relapsed/refractory MM in CARTITUDE-1, -2, and -4
Leerink Partnrs Has Positive Outlook for BMY FY2026 Earnings
Longfellow Investment Management Co. LLC Grows Stock Holdings in Bristol Myers Squibb Company $BMY
Elo Mutual Pension Insurance Co Buys 9,352 Shares of Bristol Myers Squibb Company $BMY - Stock Observer
Healthcare Stocks Gain Ground - Healthcare Roundup | Morningstar
Rep. Gilbert Ray Cisneros, Jr. Sells Bristol Myers Squibb Company (NYSE:BMY) Shares - Markets Daily
Prudential Financial Inc. Purchases 2,334,421 Shares of Bristol Myers Squibb Company $BMY
Bayer's stock is jumping on a stroke drug trial - and so is Bristol Myers Squibb | Morningstar
Company Website: https://www.bms.com PRINCETON, N.J. -- (B
Bristol Myers Squibb Company $BMY Stock Position Decreased by Fiducient Advisors LLC
Horizon Kinetics Asset Management LLC Increases Stock Holdings in Bristol Myers Squibb Company $BMY - Daily Political
BristolMyers News
Top cryptos to watch 2026: Bitcoin (BTC/USD), Starknet, Pi Network (PI) coin
Bitcoin (BTC) Price Prediction: How much will $1 Bitcoin be worth in 2026?
RGTI stock crashed 7% today: what’s happening with Rigetti Computing?
Gold price analysis: XAU/USD price today, how high will gold go in 2026?
Technology stock to watch in 2026: What is the new NVDA stock price target?
